Consistent with these reports, our study also demonstrated that EZH2 enhanced the expressions of stemness-associated TF genes, SOX2, OCT4, and Nanog, as well as SUZ12 in the drug-resistant breast cancer cells. Here, SOX2 is linked to breast carcinoma.